Maravai LifeSciences Holdings, Inc. (MRVI) Profit Margins
Over the twelve months to 2026-06-30, Maravai LifeSciences Holdings, Inc. (MRVI) had gross margin 34.9%, operating margin -56.1%, net margin -37.1%, free cash flow margin -17.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MRVIMaravai LifeSciences Holdings, Inc.Follow MRVI — free
—
Price chart with a free account
- Market cap
- 1.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Gross margin | 82.4% | 80.9% | 48.5% | 41.8% | 18.3% | 34.9% | |
| Operating margin | 69.4% | 65.0% | -11.0% | -90.9% | -115.9% | -56.1% | |
| Net margin | 22.8% | 24.9% | -41.2% | -55.9% | -70.4% | -37.1% | |
| FCF margin | 44.3% | 58.8% | 21.0% | -8.6% | -38.1% | -17.2% |
USD billions · SEC XBRL
Maravai LifeSciences Holdings, Inc. — questions
- What is Maravai LifeSciences Holdings, Inc.'s gross margin?
- 34.9% over the twelve months to 2026-06-30.
- What is Maravai LifeSciences Holdings, Inc.'s operating margin?
- -56.1% over the twelve months to 2026-06-30.
- What is Maravai LifeSciences Holdings, Inc.'s net profit margin?
- -37.1% over the twelve months to 2026-06-30.
Every figure on this page comes from Maravai LifeSciences Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.